Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
ANNX Annexon
- 1.880
- -0.030-1.57%
Close Apr 25 16:00 ET
- 1.880
- 0.000-0.02%
Pre 08:00 ET
206.26MMarket Cap-1.86P/E (TTM)
1.900High1.800Low877.98KVolume1.890Open1.910Pre Close1.63MTurnover1.07%Turnover RatioLossP/E (Static)109.71MShares7.85052wk High0.70P/B153.70MFloat Cap1.28552wk Low--Dividend TTM81.75MShs Float38.010Historical High--Div YieldTTM5.24%Amplitude1.285Historical Low1.855Avg Price1Lot Size
About Annexon Company
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Company Profile
SymbolANNX
Company NameAnnexon
Listing DateJul 24, 2020
Issue Price17.00
Founded2011
CEOMr. Douglas Love, Esq.
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address1400 Sierra Point Parkway,Building C,Suite 200
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-822-5500
Websitehttp://www.annexonbio.com
Company Executives
- Name
- Position
- Salary
- Douglas Love, Esq.
- President, Chief Executive Officer and Director
- 3.67M
- Jennifer Lew
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Ted Yednock,PhD
- Executive Vice President and Chief Innovation Officer
- 1.56M
- Michael Overdorf
- Executive Vice President and Chief Business Officer
- --
- Dr. Jamie Dananberg, M.D.
- Executive Vice President and Chief Medical Officer
- 1.56M
- Dr. Dean Richard Artis, PhD
- Executive Vice President and Chief Scientific Officer
- --
- Thomas G. Wiggans
- Chairman of the Board
- 323.49K
- William B.J. Jones, Jr
- Director
- --
- Jung E. Choi
- Independent Director
- 296.49K
- William D. Waddill
- Independent Director
- 302.74K
- Muneer A. Satter
- Independent Director
- 298.11K
- Dr. William H. Carson, M.D.
- Independent Director
- 296.49K
- Dr. Bettina M. Cockroft, M.D.
- Independent Director
- 294.36K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
